United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

According to the International Data Corporation (IDC), Q3 2024 saw a total of 39.6 million tablets shipped worldwide, which represents a YoY growth of 20.4%. Apple maintains the top spot within ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...

Vivo has confirmed that it will announce the Vivo Y300 5G in India on Nov. 21. While the company already has the phone’s rear ...

Vivo is gearing up to launch its highly anticipated X200 series in Malaysia on November 19th, 2024. This confirmation follows ...

The Zara X Kate Moss collection launches on 30th November in store and online, and will comprise of ready-to-wear pieces and ...

On November 21, Vivo will unveil the Y300 5G in India. Priced between ₹21-25 thousand, it offers 8GB RAM, 128GB/256GB storage ...

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune ...

Therapies for obesity and inhibitors for lipoprotein(a) (Lp[a]) are among those to be featured at the American Heart ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Through its X handle, Vivo India announced that the Vivo Y300 5G will be unveiled in India on November 21. As per the post, ...